A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Bone & Soft Tissue Cancer (Sarcoma) Bookmark and Share

Pediatric Musculoskeletal Cancer and Sarcoma Program

Every day, City of Hope treats patients of all ages – children, adolescents and adults – who are referred to us by physicians from California and throughout the U.S.
 
Children with musculoskeletal cancers find more than hope here. They and their families find expedited diagnosis and rapid treatment that begins in hours or days, not weeks. Because musculoskeletal cancers can be especially aggressive and fast-growing, our team of specialists and clinicians collaborate efficiently on the best course of treatment for each patient.
 
Treatment for these bone and soft tissue cancers combines chemotherapy and other drugs with surgery and radiation. City of Hope researchers pioneered the use of hematopoietic cell transplantation (HCT) as a treatment option for patients with advanced sarcoma, and a current study involves the use of new imaging techniques, novel radiation oncology techniques and HCT. Our approach integrates powerful new anti-cancer drugs with alternative therapies in an effort to spare patients’ limbs. We are successful in this effort in 85 percent of our cases.

We are one of the few centers in the nation that perform limb-sparing reconstruction using expandable prosthetic implants for children and adolescents. These prostheses “grow” with patients as they are expanded using noninvasive or minimally invasive techniques. This allows us to accommodate for your child’s continued growth without multiple major surgeries. Using these devices, we are able to remove bone cancer and save limbs, while at the same time reducing the number of surgeries and improving recovery time.
 
As part of the Pediatric Musculoskeletal Cancer and Sarcoma Program, care is provided by a multidisciplinary team of surgical oncologists, medical oncologists and radiation oncologists who work together with pathologists, radiologists, rehabilitation experts and others to achieve the best possible outcomes for patients. To help patients and families adjust during treatment and rehabilitation, psychologists, psychiatrists, social workers and child life specialists provide psychosocial support. Our team includes:

Judith K. Sato, M.D., director
George T. Calvert, M.D.
Dominic Femino, M.D.
James S. Miser, M.D.
Helen Mormann, F.N.P.
Margarita Munoz, PA-C
Amy Tafel, M.S.W.

A unique benefit of being treated at City of Hope is that we treat patients of all ages in our musculoskeletal program. If your child relapses or requires continued treatment or follow-up into adulthood, your family can stay with a team you know and trust, providing greater continuity of care.

As one of a handful of institutes to attain the elite designation of  Comprehensive Cancer Center by the National Cancer Institute (NCI), City of Hope is acknowledged as a leader in cancer research and treatment. Here, your child has access to innovative clinical trials, researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating soft tissue sarcoma and bone cancer. We are actively developing tomorrow’s treatments today, and our musculoskeletal investigators are collaborating with other scientists in other disciplines to develop promising new treatments.
 
For more information about our musculoskeletal treatments and research, visit our Musculoskeletal Cancer and Sarcoma Program website.
 

Bone & Soft Tissue Cancer (Sarcoma)

Pediatric Musculoskeletal Cancer and Sarcoma Program

Every day, City of Hope treats patients of all ages – children, adolescents and adults – who are referred to us by physicians from California and throughout the U.S.
 
Children with musculoskeletal cancers find more than hope here. They and their families find expedited diagnosis and rapid treatment that begins in hours or days, not weeks. Because musculoskeletal cancers can be especially aggressive and fast-growing, our team of specialists and clinicians collaborate efficiently on the best course of treatment for each patient.
 
Treatment for these bone and soft tissue cancers combines chemotherapy and other drugs with surgery and radiation. City of Hope researchers pioneered the use of hematopoietic cell transplantation (HCT) as a treatment option for patients with advanced sarcoma, and a current study involves the use of new imaging techniques, novel radiation oncology techniques and HCT. Our approach integrates powerful new anti-cancer drugs with alternative therapies in an effort to spare patients’ limbs. We are successful in this effort in 85 percent of our cases.

We are one of the few centers in the nation that perform limb-sparing reconstruction using expandable prosthetic implants for children and adolescents. These prostheses “grow” with patients as they are expanded using noninvasive or minimally invasive techniques. This allows us to accommodate for your child’s continued growth without multiple major surgeries. Using these devices, we are able to remove bone cancer and save limbs, while at the same time reducing the number of surgeries and improving recovery time.
 
As part of the Pediatric Musculoskeletal Cancer and Sarcoma Program, care is provided by a multidisciplinary team of surgical oncologists, medical oncologists and radiation oncologists who work together with pathologists, radiologists, rehabilitation experts and others to achieve the best possible outcomes for patients. To help patients and families adjust during treatment and rehabilitation, psychologists, psychiatrists, social workers and child life specialists provide psychosocial support. Our team includes:

Judith K. Sato, M.D., director
George T. Calvert, M.D.
Dominic Femino, M.D.
James S. Miser, M.D.
Helen Mormann, F.N.P.
Margarita Munoz, PA-C
Amy Tafel, M.S.W.

A unique benefit of being treated at City of Hope is that we treat patients of all ages in our musculoskeletal program. If your child relapses or requires continued treatment or follow-up into adulthood, your family can stay with a team you know and trust, providing greater continuity of care.

As one of a handful of institutes to attain the elite designation of  Comprehensive Cancer Center by the National Cancer Institute (NCI), City of Hope is acknowledged as a leader in cancer research and treatment. Here, your child has access to innovative clinical trials, researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating soft tissue sarcoma and bone cancer. We are actively developing tomorrow’s treatments today, and our musculoskeletal investigators are collaborating with other scientists in other disciplines to develop promising new treatments.
 
For more information about our musculoskeletal treatments and research, visit our Musculoskeletal Cancer and Sarcoma Program website.
 
Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...
  • When Gilbert Fresquez, 72, lost an excessive amount of weight in late 2012, he didn’t think much of it. He assumed it was a side effect from a recent surgery to remove a carcinoid tumor in his small intestine. It wasn’t until a couple of years later during a routine doctor’s visit that the retired […]